Trade Summary

2 days ago, Brennan Aoife, serving as President and CEO at Climb Bio, Inc. (CLYM), sold 30,902 shares at $13.17 per share, for a total transaction value of $406,979.34. Following this transaction, Brennan Aoife now holds 87,731 shares of CLYM.

This sale represents a 26.05% decrease in Brennan Aoife's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 29, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 30, 2026 at 7:50 PM ET, 1 day after the trade was made.

Climb Bio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.